Anja Sandström

1.2k total citations
52 papers, 756 citations indexed

About

Anja Sandström is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Anja Sandström has authored 52 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Hepatology and 14 papers in Infectious Diseases. Recurrent topics in Anja Sandström's work include Hepatitis C virus research (17 papers), Chemical Synthesis and Analysis (14 papers) and Neuropeptides and Animal Physiology (13 papers). Anja Sandström is often cited by papers focused on Hepatitis C virus research (17 papers), Chemical Synthesis and Analysis (14 papers) and Neuropeptides and Animal Physiology (13 papers). Anja Sandström collaborates with scholars based in Sweden, South Africa and Japan. Anja Sandström's co-authors include U. Helena Danielson, Eva Åkerblom, Per I. Arvidsson, Sanjay R. Borhade, Rebecca Fransson, Anders Karlén, Mathias Hallberg, Per Artursson, Richard Svensson and Fred Nyberg and has published in prestigious journals such as Neuroscience, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anja Sandström

51 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Sandström Sweden 17 351 296 153 118 118 52 756
Samuel W. Gerritz United States 16 319 0.9× 439 1.5× 61 0.4× 192 1.6× 41 0.3× 38 820
Ian Stansfield United Kingdom 15 203 0.6× 272 0.9× 256 1.7× 59 0.5× 177 1.5× 23 745
Robert G. Gentles United States 17 221 0.6× 345 1.2× 100 0.7× 33 0.3× 86 0.7× 36 669
John K. Pratt United States 15 311 0.9× 207 0.7× 186 1.2× 15 0.1× 134 1.1× 23 711
John W. Butcher United States 11 199 0.6× 180 0.6× 46 0.3× 34 0.3× 35 0.3× 14 407
Christine Fandozzi United States 11 106 0.3× 166 0.6× 296 1.9× 46 0.4× 194 1.6× 21 579
Bheemarao G. Ugarkar United States 16 311 0.9× 378 1.3× 43 0.3× 67 0.6× 236 2.0× 24 791
Weixu Zhai United States 13 227 0.6× 230 0.8× 56 0.4× 72 0.6× 18 0.2× 25 450
Genadiy Kalayanov Sweden 9 86 0.2× 226 0.8× 36 0.2× 40 0.3× 76 0.6× 20 387
Ed W. McLean United States 16 402 1.1× 290 1.0× 33 0.2× 24 0.2× 198 1.7× 28 678

Countries citing papers authored by Anja Sandström

Since Specialization
Citations

This map shows the geographic impact of Anja Sandström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Sandström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Sandström more than expected).

Fields of papers citing papers by Anja Sandström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Sandström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Sandström. The network helps show where Anja Sandström may publish in the future.

Co-authorship network of co-authors of Anja Sandström

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Sandström. A scholar is included among the top collaborators of Anja Sandström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Sandström. Anja Sandström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Sha, Bo Lundgren, Katharina Klöditz, et al.. (2024). Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors. European Journal of Medicinal Chemistry. 278. 116790–116790. 1 indexed citations
2.
Akaberi, Dario, Janina Krambrich, J.M. Berger, et al.. (2024). Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrobial Agents and Chemotherapy. 68(10). e0090924–e0090924. 4 indexed citations
3.
Akaberi, Dario, Praveen K. Chinthakindi, T. Nyman, et al.. (2021). Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors. Antiviral Research. 190. 105074–105074. 14 indexed citations
4.
Lu, Lu, Sha Cao, Edouard Zamaratski, et al.. (2021). Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation. European Journal of Medicinal Chemistry. 224. 113699–113699. 16 indexed citations
5.
Guo, Ning, et al.. (2020). The amino-terminal heptapeptide of the algesic substance P provides analgesic effect in relieving chronic neuropathic pain. European Journal of Pharmacology. 892. 173820–173820. 3 indexed citations
6.
Barlow, Νicholas, Jonas Sävmarker, Anja Sandström, et al.. (2020). Macrocyclic peptidomimetics as inhibitors of insulin-regulated aminopeptidase (IRAP). RSC Medicinal Chemistry. 11(2). 234–244. 14 indexed citations
7.
Leśniak, Anna, Christian Sköld, Maria Karlgren, et al.. (2018). An imidazole based H-Phe-Phe-NH2 peptidomimetic with anti-allodynic effect in spared nerve injury mice. Bioorganic & Medicinal Chemistry Letters. 28(14). 2446–2450. 3 indexed citations
8.
Abdurakhmanov, Eldar, Eva Åkerblom, Peter Brandt, et al.. (2018). Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold. European Journal of Medicinal Chemistry. 148. 453–464. 5 indexed citations
9.
Leśniak, Anna, Fabienne Z. Gaugaz, Richard Svensson, et al.. (2017). Importance of N- and C-terminal residues of substance P 1–7 for alleviating allodynia in mice after peripheral administration. European Journal of Pharmaceutical Sciences. 106. 345–351. 7 indexed citations
10.
Abdurakhmanov, Eldar, Eva Åkerblom, Peter Brandt, et al.. (2016). Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. Bioorganic & Medicinal Chemistry. 24(12). 2603–2620. 5 indexed citations
11.
Jönsson, Anna K., Rebecca Fransson, Hiroyuki Watanabe, et al.. (2015). Small constrained SP1–7 analogs bind to a unique site and promote anti-allodynic effects following systemic injection in mice. Neuroscience. 298. 112–119. 8 indexed citations
12.
Gao, Tianle, Jing‐Xia Hao, Rebecca Fransson, et al.. (2014). N-terminal truncations of substance P1–7 amide affect its action on spinal cord injury-induced mechanical allodynia in rats. European Journal of Pharmacology. 738. 319–325. 11 indexed citations
13.
Åkerblom, Eva, et al.. (2011). P2–P1′ macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis. Bioorganic & Medicinal Chemistry. 19(16). 4917–4927. 9 indexed citations
14.
Ohsawa, Masahiro, Anna Carlsson, Takayuki KOIZUMI, et al.. (2010). The effect of substance P1–7 amide on nociceptive threshold in diabetic mice. Peptides. 32(1). 93–98. 11 indexed citations
15.
Gising, Johan, et al.. (2010). Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones. Bioorganic & Medicinal Chemistry. 18(17). 6512–6525. 15 indexed citations
16.
Zhou, Qin, Anna Carlsson, Milad Botros, et al.. (2009). The C-terminal amidated analogue of the substance P (SP) fragment SP1–7 attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats. Peptides. 30(12). 2418–2422. 12 indexed citations
17.
Sandström, Anja, et al.. (2008). New Developments in the Discovery of Agents to Treat Hepatitis C. Current Topics in Medicinal Chemistry. 8(7). 533–562. 23 indexed citations
18.
Poliakov, Anton, Anja Sandström, Eva Åkerblom, & U. Helena Danielson. (2007). Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(2). 191–199. 11 indexed citations
19.
Gossas, Thomas, et al.. (2007). Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(12). 4057–4068. 45 indexed citations
20.
Åkerblom, Eva, Thomas Gossas, Yogesh Sabnis, et al.. (2006). Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(3). 1448–1474. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel W. Gerritz Breakdown of academic impact, for papers by Ian Stansfield Breakdown of academic impact, for papers by Robert G. Gentles Breakdown of academic impact, for papers by John K. Pratt Breakdown of academic impact, for papers by John W. Butcher Breakdown of academic impact, for papers by Christine Fandozzi Breakdown of academic impact, for papers by Bheemarao G. Ugarkar Breakdown of academic impact, for papers by Weixu Zhai Breakdown of academic impact, for papers by Genadiy Kalayanov Breakdown of academic impact, for papers by Ed W. McLean
Rankless by CCL
2026